Filing Details

Accession Number:
0001179110-17-010734
Form Type:
4
Zero Holdings:
No
Publication Time:
2017-07-27 16:09:26
Reporting Period:
2017-07-25
Filing Date:
2017-07-27
Accepted Time:
2017-07-27 16:09:26
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1556263 Syros Pharmaceuticals Inc. SYRS () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1490283 A Richard Young C/O Syros Pharmaceuticals, Inc.
620 Memorial Drive, Suite 300
Cambridge MA 02139
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2017-07-25 3,282 $22.09 423,383 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Footnotes
  1. The sales reported on this Form 4 were effected pursuant to a trading plan adopted pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended.
  2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $22.00 to $22.43, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.